The Journal for Nurse Practitioners
Volume 6, Issue 3 , Pages 193-198 , March 2010

Complementary Therapies in Osteoporosis

  • Darlene Higgs

      Affiliations

    • Darlene Higgs, RN, BSN, is an NP student at the University of Tampa in Tampa, FL.
  • ,
  • Cathy Kessenich

      Affiliations

    • Cathy Kessenich, DSN, ARNP, is a professor of nursing at the University of Tampa in Florida.

References 

  1. Alliance for Aging Research  . The Silver Book: Osteoporosis, 2009 . Available at: http://www.silverbook.org/OsteoporosisSilverbook.pdf Accessed March 30, 2009.
  2. Dahl SG , Allain P , Marie PJ , et al.   Incorporation and distribution of strontium in bone . Bone . 2001;28:446–453
  3. Fonseca JE . Rebalancing bone turnover in favor of formation with strontium ranelate: implications for bone strength . Rheumatology . 2008;47:iv17–iv19
  4. O'Donnell S , Cranney A , Wells GA , Adachi JD , Reginster JY . Strontium ranelate for preventing and treating postmenopausal osteoporosis (review) . Cochrane Database of Systematic Reviews . 2008;3
  5. National Osteoporosis Foundation  . Clinicians Guide to Prevention and Treatment of Osteoporosis, 2008 . Available at: http://www.nof.org/professionals/NOF_Clinicians_Guide.pdf Accessed February 30, 2009.
  6. Jamal SA . New Treatment Modalities for Osteoporosis. Canadian Orthopaedic Association . Available at: http://www.coa-aco.org/coa_bulletin/issue_73/jamal_new_treatment_modalities_for_osteoporosis.html Accessed March 31, 2009.
  7. Ortolani S , Silvia V . Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages . Bone . 2006;38:S19–S22
  8. Meunier PJ , Roux C , Seeman E , et al.   The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis . N Engl J Med . 2004;350:459
  9. Reginster JY , Seeman E , De Vernejoul MC , et al.   Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis. Treatment of Peripheral Osteoporosis (TROPOS) study . J Clin Endocrinol Metab . 2005;90:2816–2822
  10. Reginster JY , Felsenberg D , Boonen S . Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: results of a five-year, randomized, placebo-controlled trial . Arthritis Rheum . 2008;58:1687–1695
  11. Roux C . Strontium ranelate: short- and long-term benefits for post-menopausal women with osteoporosis . Rheumatology . 2008;47:iv20–iv22
  12. Servier  . Protelos . Available at: http://www.servier.co.uk/pdfs/Protelos_SPC.pdf Accessed March 20, 2009.
  13. Ma DF , Qin LQ , Wang PY , Katoh R . Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials . Clin Nutr . 2008;27:57–64
  14. Valtuena S , Cashman K , Robins SP , Cassicy A , Kardinaal A , Branca F . Investigating the role of natural phytoestrogens on bone health in post-menopausal women . Br J Nutr . 2003;89:S87–S99
  15. Wang J , Shang F , Liu L , Wang S , Wang J , Mei Q . In vivo and in vitro activity of genistein in osteoporosis . Ind J Pharmacol . 2007;39:103–106
  16. Morabito N , Crisafulli A , Vergara C , et al.   Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study . J Bone Miner Res . 2002;17:1904–1912
  17. Marini H , Minutoli L , Polito F , et al.   Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women . Ann Intern Med . 2007;146:839–847
  18. Marini H , Bitto A , Altavilla D , et al.   Breast safety and efficacy of genistein aglycone for post-menopausal bone loss: a follow-up study . J Clin Endocrinol Metab . 2008;
  19. Cotter A , Cashman KD . Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy . Nutr Rev . 2003;61:346–351
  20. Kuiper GG , Lemmen JC , Carlsson B , et al.   Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β . Endocrinology . 1998;139:4252–4263
  21. Tham DM , Gardner CD , Haskell WL . Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence . J Clin Endocrinol Metab . 1998;83:2223–2235
  22. Ozturk Turhan N , Bolkan F , Iltemir Duvan C , Ardicoglu Y . The effect of isoflavones on bone mass and bone remodeling markers in postmenopausal women . Turk J Med Sci . 2008;38:145–152
  23. Iwamoto J , Takeda T , Sato Y . Menatetrenone (Vitamin K2) and bone quality in treatment of postmenopausal osteoporosis . Nutr Rev . 2006;64:509–517
  24. Nieves JW . Osteoporosis: the role of micronutrients . Am J Clin Nutr . 2005;81:1232S–1239S
  25. Adams J , Pepping J . Vitamin K in the treatment and prevention of osteoporosis and arterial calcification . Am J Health Syst Pharm . 2005;62:1574–1581
  26. Cockayne S , Adamson J , Lanham-New S , Shearer MJ , Gilbody S , Togerson DJ . Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials . Arch Intern Med . 2006;166:1256–1261
  27. Purwosunu Y , Muharram  , Rachman IA , Reksoprodjo S , Sekizawa A . Vitamin K2 treatment for postmenopausal osteoporosis in Indonesia . J Obstet Gynaecol Res . 2006;32:230–234
  28. Knapen MH , Nieuwenhuijzen Kruseman AC , Wouters RS , et al.   Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause . Calcif Tissue Int . 1998;63:375–379
  29. Vergnaud P , Garnero P , Meunier PJ , et al.   Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS study . J Clin Endocrinol Metab . 1997;82:719–724
  30. Booth SL , Suttie JW . Dietary intake and adequacy of vitamin K . J Nutr . 1998;128:785–788
  31. Booth SL , Tucker KL , Chen H , et al.   Dietary vitamin K intake and hip fractures in women: a prospective study . Am J Clin Nutr . 2000;71:1201–1208
  32. Feskanish D , Weber P , Willett WC , et al.   Vitamin K intake and hip fractures in women: a prospective study . Am J Clin Nutr . 1999;69:74–79
  33. Cheung AM , Tile L , Lee Y , et al.   Vitamin K supplementation in postmenopausal women with osteopenia (ECKO Trial): a randomized controlled trial . PLoS Med . 2008;5:1461–1472
  34. Iwamoto J , Takeda T , Ichimura S . Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis . J Orthop Sci . 2000;5:546–551
  35. Iwamoto J , Takeda T , Ichimura S . Treatment with vitamin D3 and/or vitamin K2 for postmenopausal osteoporosis . Keio J Med . 2003;52:147–150
  36. Plaza SM , Lamson DW . Vitamin K2 in bone metabolism and osteoporosis . Altern Med Rev . 2005;10:24–35
  37. Fischback F , Dunning MB . A manual of laboratory and diagnostic tests . 8th ed.. New York: Lippincott Williams & Wilkins; 2008;

 In compliance with national ethical guidelines, the authors report no relationships with business or industry that would pose a conflict of interest.

PII: S1555-4155(09)00588-1

doi: 10.1016/j.nurpra.2009.10.003

The Journal for Nurse Practitioners
Volume 6, Issue 3 , Pages 193-198 , March 2010